Health & Fitness
Health and Fitness
Health and Fitness 
Thu, June 10, 2010
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - WOPRAI
[ Thu, Jun 10th 2010
] - WOPRAI
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
[ Thu, Jun 10th 2010
] - Market Wire
Wed, June 9, 2010
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
John G. McHutchison, MD, se incorpora a Gilead Sciences como Vicepresidente senior de tratamientos para enfermedades hepticas
FOSTER CITY, California--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq: GILD) ha comunicado que John G. McHutchison, MD, se incorporar a la empresa como Vicepresidente de la unidad de tratamientos para enfermedades hepticas. Adems, el Dr. McHutchison estar bajo las rdenes de Norbert W. Bischofberger, PhD, Vicepresidente ejecutivo de I+D y Director general cientfico, y ser responsable de las estrategias I+D de Gilead para respaldar los programas de la empresa en materia de enfermedades hepticas, incluida la hepatitis C.
El Dr. McHutchison tambi©n se incorporar al Comit© ejecutivo de Gilead.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.